MOH
- Status: likely_approved
🇮🇱 Dihydroergocriptine in Israel
Dihydroergocriptine (dihydroergocryptine) regulatory status in Israel.
Marketing authorisation
Dihydroergocriptine in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in Israel
Frequently asked questions
Is Dihydroergocriptine approved in Israel?
Yes. MOH has authorised it.
Who is the marketing authorisation holder for Dihydroergocriptine in Israel?
Marketing authorisation holder not available in our data.